Insider Trading activities of Ardelyx, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Ardelyx, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Ardelyx, Inc. since year 2005. Table 2 shows the detailed insider transactions of Ardelyx, Inc. since 2005. The reporting company's ticker symbol is ARDX. The reporting company's CIK number is 1437402.
The total value of stock buying since 2005 is $684,156,851.
The total value of stock sales since 2005 is $14,290,367.
The total value of stock option exercises since 2005 is $58,225.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Ardelyx, Inc. (ARDX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-01 0 $0 37,506 $63,801 0 $0
2018-11 0 $0 25,779 $73,294 0 $0
2018-05 10,000 $40,000 0 $0 0 $0
2017-10 0 $0 10,008 $52,041 0 $0
2017-08 0 $0 485 $2,400 0 $0
2017-04 0 $0 2,051 $24,577 0 $0
2017-03 0 $0 5,026 $69,093 3,000 $1,620
2017-02 0 $0 3,000 $36,000 3,000 $1,620
2017-01 0 $0 6,130 $79,383 0 $0
2016-12 0 $0 900 $13,035 0 $0
2016-11 0 $0 2,158 $32,646 0 $0
2016-10 0 $0 6,000 $90,000 6,000 $3,240
2016-09 0 $0 11,859 $136,882 10,000 $14,965
2016-07 23,673,162 $206,666,696 0 $0 0 $0
2016-03 15,000 $116,535 1,128 $12,110 0 $0
2016-02 0 $0 5,000 $51,270 5,000 $2,700
2016-01 15,500,000 $155,000,000 0 $0 0 $0
2015-12 5,000 $100,000 2,000 $40,000 2,000 $1,080
2015-11 0 $0 2,000 $40,000 2,000 $1,080
2015-10 0 $0 2,000 $39,760 2,000 $1,080
2015-09 0 $0 19,798 $402,282 2,000 $1,080
2015-08 0 $0 3,404 $66,220 2,000 $1,080
2015-07 0 $0 19,122 $347,124 10,000 $6,750
2015-06 29,028,691 $310,651,868 0 $0 0 $0
2015-05 0 $0 9,083 $98,232 9,083 $4,904
2015-04 0 $0 7,681 $98,332 7,681 $4,147
2015-03 0 $0 10,293 $161,549 6,075 $3,280
2015-02 0 $0 8,888 $146,180 8,888 $9,599
2015-01 0 $0 470,000 $11,927,900 0 $0
2014-12 0 $0 8,747 $186,256 0 $0
2014-06 827,268 $11,581,752 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Ardelyx, Inc. insiders (ARDX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-01-02 Rosenbaum David P. (Chief Development Officer) Sale 6,386 1.70 10,868
2019-01-02 Kaufmann Mark (Chief Financial Officer) Sale 6,556 1.70 11,151
2019-01-02 Raab Michael (President & CEO) Sale 19,644 1.70 33,414
2019-01-02 Grammer Elizabeth A (EVP, General Counsel) Sale 4,920 1.70 8,368
2018-11-13 Rosenbaum David P. (Chief Development Officer) Sale 5,570 2.84 15,818
2018-11-13 Kaufmann Mark (Chief Financial Officer) Sale 6,539 2.84 18,570
2018-11-13 Raab Michael (President & CEO) Sale 6,539 2.84 18,570
2018-11-13 Grammer Elizabeth A (EVP, General Counsel) Sale 6,539 2.84 18,570
2018-11-12 Sandell Scott D (10% Owner) Sale 592 2.98 1,766
2018-05-30 Ringold Gordon Buy 10,000 4.00 40,000
2017-10-24 Seeto Reginald (Chief Operating Officer) Sale 10,008 5.20 52,041
2017-08-30 Baskett Forest (10% Owner) Sale 485 4.95 2,400
2017-04-18 Rosenbaum David P. (Chief Development Officer) Sale 2,051 11.98 24,577
2017-03-10 Rosenbaum David P. (SVP, Drug Development) Sale 1,000 13.48 13,482
2017-03-03 Caldwell Jeremy S (EVP, Chief Scientific Officer) Sale 1,026 14.14 14,511
2017-03-01 Jacobs Jeffrey W (SVP, Technical Operations) Sale 3,000 13.70 41,100
2017-03-01 Jacobs Jeffrey W (SVP, Technical Operations) Option Ex 3,000 .54 1,620
2017-02-01 Jacobs Jeffrey W (SVP, Technical Operations) Sale 3,000 12.00 36,000
2017-02-01 Jacobs Jeffrey W (SVP, Technical Operations) Option Ex 3,000 .54 1,620
2017-01-05 Korner Paul (EVP, Chief Medical Officer) Sale 6,130 12.95 79,383
2016-12-16 Rosenbaum David P. (SVP, Drug Development) Sale 900 14.48 13,035
2016-11-11 Caldwell Jeremy S (EVP, Chief Scientific Officer) Sale 2,158 15.13 32,646
2016-10-11 Jacobs Jeffrey W (SVP, Technical Operations) Sale 6,000 15.00 90,000
2016-10-11 Jacobs Jeffrey W (SVP, Technical Operations) Option Ex 6,000 .54 3,240
2016-09-23 Grammer Elizabeth A (SVP, General Counsel) Sale 3,560 12.00 42,720
2016-09-23 Grammer Elizabeth A (SVP, General Counsel) Option Ex 3,560 2.25 8,010
2016-09-22 Grammer Elizabeth A (SVP, General Counsel) Sale 1,440 12.00 17,280
2016-09-22 Grammer Elizabeth A (SVP, General Counsel) Option Ex 1,440 1.08 1,555
2016-09-19 Grammer Elizabeth A (SVP, General Counsel) Sale 6,859 11.21 76,882
2016-09-19 Grammer Elizabeth A (SVP, General Counsel) Option Ex 5,000 1.08 5,400
2016-07-18 Nea 15 Gp, Llc (10% Owner) Buy 1,527,301 8.73 13,333,337
2016-07-18 Sakoda Jon (10% Owner) Buy 1,527,301 8.73 13,333,337
2016-07-18 Florence Anthony A. Jr. (10% Owner) Buy 1,527,301 8.73 13,333,337
2016-07-18 Sonsini Peter W. (10% Owner) Buy 1,527,301 8.73 13,333,337
2016-07-18 Viswanathan Ravi (10% Owner) Buy 1,527,301 8.73 13,333,337
2016-07-18 Nea 12 Gp, Llc (10% Owner) Buy 763,650 8.73 6,666,664
2016-07-18 Weller Harry R (10% Owner) Buy 1,527,301 8.73 13,333,337
2016-07-18 Baskett Forest (10% Owner) Buy 2,290,951 8.73 20,000,002
2016-07-18 Kolluri Krishna Kittu (10% Owner) Buy 2,290,951 8.73 20,000,002
2016-07-18 Sandell Scott D (10% Owner) Buy 2,290,951 8.73 20,000,002
2016-07-18 Makower Joshua (10% Owner) Buy 1,527,301 8.73 13,333,337
2016-07-18 Kerins Patrick J (10% Owner) Buy 763,650 8.73 6,666,664
2016-07-18 Mott David M (Director) Buy 1,527,301 8.73 13,333,337
2016-07-18 Barrett M James (10% Owner) Buy 763,650 8.73 6,666,664
2016-07-18 Barris Peter J (10% Owner) Buy 2,290,951 8.73 20,000,002
2016-03-21 Ringold Gordon Buy 15,000 7.77 116,535
2016-03-03 Rosenbaum David P. (SVP, Drug Development) Sale 1,128 10.74 12,110
2016-02-16 Kaufmann Mark (Chief Financial Officer) Sale 5,000 10.25 51,270
2016-02-16 Kaufmann Mark (Chief Financial Officer) Option Ex 5,000 .54 2,700
2016-01-13 Nea 15 Gp, Llc (10% Owner) Buy 1,000,000 10.00 10,000,000
2016-01-13 Sakoda Jon (10% Owner) Buy 1,000,000 10.00 10,000,000
2016-01-13 Florence Anthony A. Jr. (10% Owner) Buy 1,000,000 10.00 10,000,000
2016-01-13 Sonsini Peter W. (10% Owner) Buy 1,000,000 10.00 10,000,000
2016-01-13 Viswanathan Ravi (10% Owner) Buy 1,000,000 10.00 10,000,000
2016-01-13 Nea 12 Gp, Llc (10% Owner) Buy 500,000 10.00 5,000,000
2016-01-13 Weller Harry R (10% Owner) Buy 1,000,000 10.00 10,000,000
2016-01-13 Baskett Forest (10% Owner) Buy 1,500,000 10.00 15,000,000
2016-01-13 Kolluri Krishna Kittu (10% Owner) Buy 1,500,000 10.00 15,000,000
2016-01-13 Sandell Scott D (10% Owner) Buy 1,500,000 10.00 15,000,000
2016-01-13 Makower Joshua (10% Owner) Buy 1,000,000 10.00 10,000,000
2016-01-13 Kerins Patrick J (10% Owner) Buy 500,000 10.00 5,000,000
2016-01-13 Mott David M (Director) Buy 1,000,000 10.00 10,000,000
2016-01-13 Barrett M James (10% Owner) Buy 500,000 10.00 5,000,000
2016-01-13 Barris Peter J (10% Owner) Buy 1,500,000 10.00 15,000,000
2015-12-17 Bertrand William C Jr Buy 5,000 20.00 100,000
2015-12-15 Jacobs Jeffrey W (SVP, Technical Operations) Sale 2,000 20.00 40,000
2015-12-15 Jacobs Jeffrey W (SVP, Technical Operations) Option Ex 2,000 .54 1,080
2015-11-27 Jacobs Jeffrey W (SVP, Technical Operations) Sale 2,000 20.00 40,000
2015-11-27 Jacobs Jeffrey W (SVP, Technical Operations) Option Ex 2,000 .54 1,080
2015-10-08 Jacobs Jeffrey W (SVP, Technical Operations) Sale 2,000 19.88 39,760
2015-10-08 Jacobs Jeffrey W (SVP, Technical Operations) Option Ex 2,000 .54 1,080
2015-09-22 Rosenbaum David P. (SVP, Drug Development) Sale 600 22.00 13,200
2015-09-21 Rosenbaum David P. (SVP, Drug Development) Sale 800 22.09 17,674
2015-09-15 Rosenbaum David P. (SVP, Drug Development) Sale 2,540 22.01 55,897
2015-09-10 Jacobs Jeffrey W (SVP, Technical Operations) Sale 2,000 20.59 41,186
2015-09-10 Jacobs Jeffrey W (SVP, Technical Operations) Option Ex 2,000 .54 1,080
2015-09-08 Raab Michael (President & CEO) Sale 9,785 20.29 198,547
2015-09-03 Rosenbaum David P. (SVP, Drug Development) Sale 1,251 19.25 24,081
2015-09-01 Caldwell Jeremy S (EVP, Chief Scientific Officer) Sale 643 18.32 11,779
2015-09-01 Rosenbaum David P. (SVP, Drug Development) Sale 1,286 18.32 23,559
2015-09-01 Grammer Elizabeth A (VP, General Counsel) Sale 893 18.32 16,359
2015-08-18 Raab Michael (President & CEO) Sale 1,104 20.00 22,080
2015-08-06 Jacobs Jeffrey W (SVP, Technical Operations) Sale 2,000 19.07 38,140
2015-08-06 Jacobs Jeffrey W (SVP, Technical Operations) Option Ex 2,000 .54 1,080
2015-08-03 Raab Michael (President & CEO) Sale 300 20.00 6,000
2015-07-30 Rosenbaum David P. (SVP, Drug Development) Sale 2,011 19.27 38,755
2015-07-28 Jacobs Jeffrey W (Senior VP, Technical Ops) Sale 2,500 20.00 50,000
2015-07-28 Jacobs Jeffrey W (Senior VP, Technical Ops) Option Ex 2,500 .54 1,350
2015-07-28 Raab Michael (President & CEO) Sale 2,111 20.00 42,220
2015-07-22 Grammer Elizabeth A (VP, General Counsel) Sale 2,500 18.00 45,000
2015-07-22 Grammer Elizabeth A (VP, General Counsel) Option Ex 2,500 1.08 2,700
2015-07-15 Grammer Elizabeth A (VP, General Counsel) Sale 10,000 17.11 171,149
2015-07-15 Grammer Elizabeth A (VP, General Counsel) Option Ex 5,000 .54 2,700
2015-06-10 Ringold Gordon Buy 10,000 15.19 151,880
2015-06-05 Nea 12 Gp, Llc (10% Owner) Buy 1,869,159 10.70 20,000,001
2015-06-05 Drant Ryan D (10% Owner) Buy 1,869,159 10.70 20,000,001
2015-06-05 Baskett Forest (10% Owner) Buy 4,672,897 10.70 49,999,997
2015-06-05 Kolluri Krishna Kittu (10% Owner) Buy 4,672,897 10.70 49,999,997
2015-06-05 Sandell Scott D (10% Owner) Buy 4,672,897 10.70 49,999,997
2015-06-05 Kerins Patrick J (10% Owner) Buy 1,869,159 10.70 20,000,001
2015-06-05 Mott David M (Director) Buy 2,803,738 10.70 29,999,996
2015-06-05 Barrett M James (10% Owner) Buy 1,869,159 10.70 20,000,001
2015-06-05 Schultz Peter G Buy 46,729 10.70 500,000
2015-06-05 Barris Peter J (10% Owner) Buy 4,672,897 10.70 49,999,997
2015-05-04 Kaufmann Mark (Chief Financial Officer) Sale 9,083 10.81 98,232
2015-05-04 Kaufmann Mark (Chief Financial Officer) Option Ex 9,083 .54 4,904
2015-04-06 Kaufmann Mark (Chief Financial Officer) Sale 7,681 12.80 98,332
2015-04-06 Kaufmann Mark (Chief Financial Officer) Option Ex 7,681 .54 4,147
2015-03-03 Kaufmann Mark (Chief Financial Officer) Sale 6,075 15.60 94,745
2015-03-03 Kaufmann Mark (Chief Financial Officer) Option Ex 6,075 .54 3,280
2015-03-02 Jacobs Jeffrey W (VP, Chemistry) Sale 981 15.81 15,513
2015-03-02 Grammer Elizabeth A (VP, General Counsel) Sale 1,737 15.81 27,470
2015-03-02 Jue George (VP, Operations) Sale 1,500 15.88 23,821
2015-02-04 Jacobs Jeffrey W (VP, Chemistry) Sale 8,888 16.45 146,180
2015-02-04 Jacobs Jeffrey W (VP, Chemistry) Option Ex 8,888 1.08 9,599
2015-01-30 Cmea Ventures Vii (parallel) Lp (10% Owner) Sale 170,000 27.37 4,652,900
2015-01-08 Cmea Ventures Vii (parallel) Lp (10% Owner) Sale 300,000 24.25 7,275,000
2014-12-29 Kolluri Krishna Kittu (10% Owner) Sale 267 20.09 5,363
2014-12-26 Baskett Forest (10% Owner) Sale 1,972 21.28 41,960
2014-12-26 Sandell Scott D (10% Owner) Sale 1,972 21.28 41,960
2014-12-26 Barrett M James (10% Owner) Sale 2,564 21.46 55,013
2014-12-26 Barris Peter J (10% Owner) Sale 1,972 21.28 41,960
2014-06-24 Cmea Ventures Vii (parallel) Lp (10% Owner) Buy 316,826 14.00 4,435,564
2014-06-24 Sandell Scott D (10% Owner) Buy 510,442 14.00 7,146,188

Insider trading activities including stock purchases, stock sales, and option exercises of ARDX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Ardelyx, Inc. (symbol ARDX, CIK number 1437402) see the Securities and Exchange Commission (SEC) website.